Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.70
-0.02 (-2.75%)
At close: May 09, 2025, 3:59 PM
0.73
4.18%
After-hours: May 09, 2025, 07:55 PM EDT
-2.75% (1D)
| Bid | 0.65 |
| Market Cap | 160.6M |
| Revenue (ttm) | 57.8M |
| Net Income (ttm) | -97.94M |
| EPS (ttm) | -0.49 |
| PE Ratio (ttm) | -1.43 |
| Forward PE | -2.06 |
| Analyst | Buy |
| Ask | 0.78 |
| Volume | 2,808,936 |
| Avg. Volume (20D) | 6,679,140 |
| Open | 0.71 |
| Previous Close | 0.72 |
| Day's Range | 0.68 - 0.73 |
| 52-Week Range | 0.30 - 3.18 |
| Beta | 1.46 |
About SGMO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SGMO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SGMO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Sangamo Therapeutics Inc. is scheduled to release its earnings on May 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-4.73%
Sangamo Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
+2.94%
Sangamo Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.
1 month ago · seekingalpha.com
Sangamo Therapeutics, Inc. (SGMO) Q4 2024 Earnings Call TranscriptSangamo Therapeutics, Inc. (NASDAQ:SGMO ) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Louise Wilkie - Vice President, Investor Relations and Corporate Communication...
